AKT1 and diabetic kidney disease: Diabetic nephropathy may be delayed / prevented by IR knockout [158], or rapamycin treatment [159], or curtailing podocytes’ mTORC1 copies [160, 161], or by suppressing Akt activity in proximal tubular cells [162], implying a role for insulin-activated mTORC1 in driving diabetic nephropathy.